
Onco Imaging and Therapeutics India
About Onco Imaging and Therapeutics India
Data last updated:
Onco Imaging and Therapeutics India is a private not for profit company based in Delhi, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 08 October 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL1996NPL082472.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹2,000. It is led by directors including Qazi Nadeem Shoket and Deepak Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D 1295, Jahangir Puri, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.25 Lakh. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 12.2%) and EBITDA of ₹2.83 Lakh (EBITDA margin 12.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Onco Imaging and Therapeutics India has one previous CIN (Corporate Identification Number): U85100DL1996PTC082472. The current CIN is U85100DL1996NPL082472, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100DL1996NPL082472 | Current |
| U85100DL1996PTC082472 | Previous |
Contact details
Onco Imaging and Therapeutics India's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD 1295, Jahangir Puri, Delhi, India – 110033
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Onco Imaging and Therapeutics India, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Onco Imaging and Therapeutics India
FY 2025 filings availableOnco Imaging and Therapeutics India reported revenue of ₹23.25 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | 12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Onco Imaging and Therapeutics India, buy the company report.
Board of directors of Onco Imaging and Therapeutics India
Onco Imaging and Therapeutics India has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kashish Vijay | Additional Director | 10 Dec 2024 | 1 Years 11 Months | Current |
| Qazi Nadeem Shoket | Director | 19 Jun 2025 | 1 Years 5 Months | Current |
| Shalabh Arora | Additional Director | 08 Feb 2025 | 1 Years 9 Months | Current |
| Deepak Singla | Director | 14 Jul 2025 | 1 Years 4 Months | Current |
Auditor
Onco Imaging and Therapeutics India is audited by ARORA VIKAS AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARORA VIKAS AND CO | FY 2017 | 533270 |
Shareholding
The shareholding of Onco Imaging and Therapeutics India is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Onco Imaging and Therapeutics India, buy the company report.
Legal cases
No court or tribunal cases involving Onco Imaging and Therapeutics India are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Onco Imaging and Therapeutics India; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Onco Imaging and Therapeutics India; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Onco Imaging and Therapeutics India has 8 board changes on record since 2021: 4 appointments and 4 cessations. The latest: Deepak Singla was appointed as Director on 14 Jul 2025.
Frequently asked questions
Onco Imaging and Therapeutics India is an active private not for profit company based in Delhi, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 08 October 1996 (30+ years old) and is registered under CIN U85100DL1996NPL082472.
Onco Imaging and Therapeutics India has 4 current directors:
- Kashish Vijay - Additional Director
- Qazi Nadeem Shoket - Director
- Shalabh Arora - Additional Director
- Deepak Singla - Director
The latest financial statements of Onco Imaging and Therapeutics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Onco Imaging and Therapeutics India is U85100DL1996NPL082472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Onco Imaging and Therapeutics India was incorporated on 08 October 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Deepak Singla was appointed as Director on 14 Jul 2025. Garima Gulati ceased to be Additional Director on 21 Jun 2025. Qazi Nadeem Shoket was appointed as Director on 19 Jun 2025. Onco Imaging and Therapeutics India has 8 board changes on record in total.
The registered office of Onco Imaging and Therapeutics India is at D 1295, Jahangir Puri, Delhi, India – 110033.
Onco Imaging and Therapeutics India operates in the healthcare industry, in the oncology clinics and cancer treatment segment.
The compliance status of Onco Imaging and Therapeutics India is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.
Onco Imaging and Therapeutics India can be reached at its registered office: D 1295, Jahangir Puri, Delhi, India – 110033.

